Loading…
Getting the latest data.
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −3.0% | −4.2% | +10.0% | +9.5% | +36.0% | +41.2% | +84.3% | +41.6% | +406.5% | +1,714.3% |
| Peer average | −1.9% | −11.6% | −23.5% | −31.7% | −13.8% | −12.4% | +76.4% | +28.7% | +275.8% | — |
| S&P 500 · VOO | −1.0% | −2.4% | −4.5% | −4.5% | +8.3% | +10.2% | +72.7% | +68.0% | +305.1% | — |
$129 of every $1,000 in RXL is Proshares
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | —Net Other Assets (Liabilities) | — | 25.79% | $2,579.25 | 30.1M | $30.1M |
| 2 | IQMMProshares Genius MNY MKT ETF | Financial Services | 12.88% | $1,287.99 | 150K | $15.0M |
| 3 | LLYELI Lilly | Healthcare | 10.34% | $1,034.13 | 8,424 | $12.1M |
| 4 | JNJJohnson & Johnson | Healthcare | 6.15% | $614.70 | 25K | $7.2M |
| 5 | ABBVAbbvie | Healthcare | 4.70% | $469.90 | 19K | $5.5M |
| 6 | UNHUnitedhealth Group | Healthcare | 3.34% | $333.86 | 9,450 | $3.9M |
| 7 | MRKMerck | Healthcare | 3.22% | $321.75 | 26K | $3.8M |
| 8 | TMOThermo Fisher Scientific | Healthcare | 2.31% | $230.77 | 3,893 | $2.7M |
| 9 | AMGNAmgen | Healthcare | 2.26% | $225.64 | 5,692 | $2.6M |
| 10 | GILDGilead Sciences | Healthcare | 1.88% | $187.59 | 13K | $2.2M |
| 11 | ABTAbbott Laboratories | Healthcare | 1.68% | $167.85 | 18K | $2.0M |
| 12 | PFEPfizer | Healthcare | 1.49% | $148.50 | 60K | $1.7M |
| 13 | ISRGIntuitive Surgical | Healthcare | 1.40% | $139.59 | 3,719 | $1.6M |
| 14 | DHRDanaher | Healthcare | 1.30% | $129.86 | 6,587 | $1.5M |
| 15 | VRTXVertex Pharmaceuticals | Healthcare | 1.23% | $123.08 | 2,669 | $1.4M |
of the $120B in 408 An index ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | IQMM | Proshares Genius MNY MKT ETF | 12.88% |
| 2 | LLY | ELI Lilly & | 10.34% |
| 3 | JNJ | Johnson & Johnson | 6.15% |
| 4 | ABBV | Abbvie | 4.70% |
| 5 | UNH | Unitedhealth Group | 3.34% |
| 6 | MRK | Merck & | 3.22% |
| 7 | TMO | Thermo Fisher Scientific | 2.31% |
| 8 | AMGN | Amgen | 2.26% |
| 9 | GILD | Gilead Sciences | 1.88% |
| 10 | ABT | Abbott Laboratories | 1.68% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Sep 23, 2026 | Sep 29, 2026 | $0.13 |
| Jun 24, 2026 | Jun 30, 2026 | $0.18 |
| Mar 25, 2026 | Mar 31, 2026 | $0.14 |
| Dec 24, 2025 | Dec 31, 2025 | $0.18 |
| Sep 24, 2025 | Sep 30, 2025 | $0.20 |
| Jun 25, 2025 | Jul 1, 2025 | $0.22 |
| Mar 26, 2025 | Apr 1, 2025 | $0.13 |
| Dec 23, 2024 | Dec 31, 2024 | $0.15 |
| Sep 25, 2024 | Oct 2, 2024 | $0.13 |
| Jun 26, 2024 | Jul 3, 2024 | $0.17 |
| Mar 20, 2024 | Mar 27, 2024 | $0.0861 |
| Dec 20, 2023 | Dec 28, 2023 | $0.0841 |